FDA | What's New Follow Amazon.com, Inc. - 662503 - 12/20/2023 Finished Pharmaceuticals/Unapproved New Drug/Misbranded http://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amazoncom-inc-662503-12202023 fda.gov
